Bradley Monk
Gynecologic Oncology · West Palm Beach, FLNPI 1487734646
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by GSK at 26.5% of the total. Among gynecologic oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,903 payments — averaging $1335.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$674K
- AstraZeneca$355K
- Merck$332K
- Genmab U.S., Inc.$155K
- Tesaro, Inc.$144K
- Seagen Inc.$112K
- plus $768K from 54 others
Across 1,285 payments — averaging $6233.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$2.8M
- Novartis$1.2M
- Merck$1.2M
- Incyte Corporation$1.1M
- Seagen Inc.$534K
- AstraZeneca$378K
- plus $718K from 12 others
What the payments were for
- Consulting fees$914,74836%
- Speaking & faculty fees$1,186,99947%
- Grants$1,0780%
- Travel & lodging$397,21816%
- Food & beverage$40,4792%
- Education$1850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEJULA$433,022
- LYNPARZA$317,605
- TIVDAK$236,278
- JEMPERLI$115,202
- Rubraca$95,249
- KEYTRUDA$82,636
- LENVIMA$79,940
- myChoice CDx$64,562
- Elahere$60,251
- Avastin$45,864
- GARDASIL$45,590
- IMFINZI$30,133
- LIBTAYO$25,856
- PreciseTumor$15,975
- BAVENCIO$12,744
- FYARRO$10,022
- Enhertu$8,417
- BENCHMARK SPECIAL STAINS WASH II$8,180
- YONDELIS$6,000
- Korlym$5,989
How this compares
$2,540,708 in reported general payments places this provider in the 95th percentile of 117 gynecologic oncology providers in Florida.
Other gynecologic oncology in West Palm Beach
- Christopher McCannWest Palm Beach$32K
- Howard GoodmanWest Palm Beach$5K
- Evan LevyWest Palm Beach$3K
- Martin MartinoJacksonville$957K
- Brian SlomovitzFort Lauderdale$519K
- Ricardo EstapeMiami$457K
- Robert HollowayOrlando$432K
- Shelly SewardOrlando$349K
- Edward GrendysFort Myers$341K
- Jonathan BlackMiramar$329K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.